23andMe Holding Co. (ME)
NASDAQ: ME
· Real-Time Price · USD
0.61
0.00 (0.61%)
At close: Mar 28, 2025, 3:59 PM
0.61% (1D)
Bid | n/a |
Market Cap | 13.34M |
Revenue (ttm) | 208.78M |
Net Income (ttm) | -382.87M |
EPS (ttm) | -17.39 |
PE Ratio (ttm) | -0.03486486486486486 |
Forward PE | -0.06 |
Analyst | Hold |
Ask | n/a |
Volume | 29,751,445 |
Avg. Volume (20D) | 4,040,716 |
Open | 0.75 |
Previous Close | 0.61 |
Day's Range | 0.61 - 0.75 |
52-Week Range | 0.48 - 12.76 |
Beta | 1.20 |
Analyst Forecast
According to 0 analyst ratings, the average rating for ME stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 months ago
23andMe shares are trading higher. The company pro...
Unlock content with
Pro Subscription
2 months ago
23andMe shares are trading lower after the company announced it has initiated voluntary Chapter 11 bankruptcy to pursue a strategic sale and secured $35M in DIP financing.

2 months ago · foxbusiness.com
23andMe probe launched to prevent customer DNA data from being sold to China or other bad actorsSen. Bill Cassidy is probing 23andMe, which recently filed for bankruptcy protection, to ensure the company does not sell customer data to China or other foreign adversaries.